Dr. Jun-Hyeog Jang's research centers on biochemical and biomaterial approaches for tissue engineering and regenerative medicine. His work focuses on recombinant extracellular matrix (ECM)-derived proteins — including laminin, elastin, and fibrillin domains — to regulate stem cell adhesion, stemness, and differentiation in human mesenchymal stem cells (MSCs), as well as engineered ECM-mimetic fusion proteins that protect MSCs from cellular senescence. Dr. Jang's contributions aim to create stable, biomimetic protein environments that enhance tissue regeneration, with significant implications for medical and therapeutic applications.
Dr. Jun-Hyeog Jang's research centers on biochemical and biomaterial approaches for tissue engineering and regenerative medicine. His work focuses on recombinant extracellular matrix (ECM)-derived proteins — including laminin, elastin, and fibrillin domains — to regulate stem cell adhesion, stemness, and differentiation in human mesenchymal stem cells (MSCs), as well as engineered ECM-mimetic fusion proteins that protect MSCs from cellular senescence. Dr. Jang's contributions aim to create stable, biomimetic protein environments that enhance tissue regeneration, with significant implications for medical and therapeutic applications.